He said there is no reason to suspend the use of the AstraZeneca coronavirus vaccine, as the European Medicines Agency (EMA) confirmed in its opinion on Wednesday that the benefits of the vaccine outweigh the risks of potential side effects. Stefan de Kirsmeiker, European Commission spokesperson on Friday.
In response to a question at a press conference at the Brussels Commission, the spokesman emphasized that although the European Union Medicines Agency said in a statement on Wednesday that it could be opposed.
Photo: Yui Mok – PA Images / Getty Images Hungary
He said that the opinion of the European Energy Agency, which confirms that citizens can have confidence in the safety and efficacy of the vaccine, is important to the European Commission. He added that the European Union Committee is monitoring the epidemiological situation and hopes that there will be a common position among member states on the use of vaccines.
To date, the European Commission has identified Johnson & Johnson (400 million doses), BioNTech-Pfizer (600 million doses), Moderna (460 million doses), AstraZeneca (400 million doses), CureVac (405 million doses), and Sanofi. -GSK. (300 million doses) signed a contract to purchase vaccines.
